AI generated summary of Pubmed citation/abstract with PMID 38093128

https://pubmed.ncbi.nlm.nih.gov/38093128

This study suggests that immunocompetent mice can be used as a model for preclinical studies of mRNA vaccine immunogenicity, as their MHC-I is capable of presenting SARS-CoV-2 S-protein peptides that are highly affine for human MHC-I and have been confirmed to be immunogenic in COVID-19 patients.